Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs CHANDRA BHAGAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES CHANDRA BHAGAT PHARMA DIVIS LABORATORIES/
CHANDRA BHAGAT PHARMA
 
P/E (TTM) x 66.0 - - View Chart
P/BV x 7.1 2.6 274.0% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   CHANDRA BHAGAT PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
CHANDRA BHAGAT PHARMA
Mar-23
DIVIS LABORATORIES/
CHANDRA BHAGAT PHARMA
5-Yr Chart
Click to enlarge
High Rs4,641136 3,412.5%   
Low Rs2,73083 3,289.2%   
Sales per share (Unadj.) Rs292.6158.5 184.6%  
Earnings per share (Unadj.) Rs68.71.2 5,730.1%  
Cash flow per share (Unadj.) Rs81.61.3 6,064.7%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs480.936.4 1,321.4%  
Shares outstanding (eoy) m265.477.55 3,516.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.60.7 1,824.5%   
Avg P/E ratio x53.791.2 58.8%  
P/CF ratio (eoy) x45.281.3 55.5%  
Price / Book Value ratio x7.73.0 254.9%  
Dividend payout %43.70-   
Avg Mkt Cap Rs m978,378826 118,420.8%   
No. of employees `000NANA-   
Total wages/salary Rs m9,75013 73,753.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,6751,197 6,490.7%  
Other income Rs m3,4473 117,631.4%   
Total revenues Rs m81,1221,200 6,762.1%   
Gross profit Rs m23,69132 74,547.2%  
Depreciation Rs m3,4321 309,171.2%   
Interest Rs m2022 89.2%   
Profit before tax Rs m23,68612 203,840.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4533 212,159.5%   
Profit after tax Rs m18,2349 201,478.5%  
Gross profit margin %30.52.7 1,148.6%  
Effective tax rate %23.022.1 104.3%   
Net profit margin %23.50.8 3,102.8%  
BALANCE SHEET DATA
Current assets Rs m97,437589 16,544.0%   
Current liabilities Rs m15,331269 5,689.0%   
Net working cap to sales %105.726.7 395.9%  
Current ratio x6.42.2 290.8%  
Inventory Days Days80 2,499.7%  
Debtors Days Days842250 337.4%  
Net fixed assets Rs m51,1287 702,306.3%   
Share capital Rs m53175 703.6%   
"Free" reserves Rs m127,140199 63,780.5%   
Net worth Rs m127,671275 46,461.3%   
Long term debt Rs m039 0.0%   
Total assets Rs m148,565606 24,522.6%  
Interest coverage x1,209.51.5 79,120.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.52.0 26.5%   
Return on assets %12.35.1 239.8%  
Return on equity %14.33.3 433.5%  
Return on capital %18.610.7 173.6%  
Exports to sales %85.748.1 178.0%   
Imports to sales %19.80-   
Exports (fob) Rs m66,537576 11,555.3%   
Imports (cif) Rs m15,378NA-   
Fx inflow Rs m66,537576 11,555.3%   
Fx outflow Rs m15,7157 225,462.0%   
Net fx Rs m50,822569 8,934.3%   
CASH FLOW
From Operations Rs m24,59753 46,727.4%  
From Investments Rs m-27,076-1 4,589,186.4%  
From Financial Activity Rs m-7,972-44 17,926.0%  
Net Cashflow Rs m-10,4518 -137,870.7%  

Share Holding

Indian Promoters % 51.9 68.7 75.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.7 2.2 1,655.0%  
FIIs % 14.9 1.3 1,116.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 31.3 153.6%  
Shareholders   354,482 134 264,538.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs CHANDRA BHAGAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs CHANDRA BHAGAT PHARMA Share Price Performance

Period Divis Laboratories CHANDRA BHAGAT PHARMA S&P BSE HEALTHCARE
1-Day 2.14% -1.04% 1.18%
1-Month -2.15% -28.89% -0.75%
1-Year 22.51% -2.06% 61.82%
3-Year CAGR -1.38% 33.64% 18.16%
5-Year CAGR 15.77% 12.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the CHANDRA BHAGAT PHARMA share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of CHANDRA BHAGAT PHARMA the stake stands at 68.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of CHANDRA BHAGAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

CHANDRA BHAGAT PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of CHANDRA BHAGAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.